Enzymatic DNA Synthesis: Shorter Waits, Longer Strands
Ansa’s enzymatic DNA synthesis is featured in Genetic Engineering & Biotechnology News.Read the article
News & Events
Webinar: Complex DNA Synthesis for Your Most Ambitious Projects
This webinar covers Ansa’s unique enzymatic approach to DNA synthesis, and how Ansa has been able to provide the Cress Lab at the Innovative Genomics Institute with access to their repetitive and complex DNA sequences that is further enabling their work in microbial engineering.
Enzymatic DNA Synthesis: Going to Great Lengths
The Scientist article highlighting the need to move beyond chemical DNA synthesis in order to continue pushing science further. Featuring Ansa co-founder and Chief Science Officer, Dan Lin-Arlow.
Ansa Biotechnologies Expands Successful Early Access Program for Complex DNA Synthesis
Ansa Biotechnologies is expanding its early access program for its complex DNA synthesis services. More customers around the world will now be able to take advantage of the company’s innovative enzymatic DNA synthesis technology to accelerate innovation in healthcare, life science research, and other industries powered by synthetic DNA. View the press release.
Ansa Biotechnologies to Showcase Early Access Customer Success at Upcoming Global Synthetic Biology Conference
Ansa Biotechnologies today announced its speaker lineup for presentations at the upcoming Global Synthetic Biology (SynBioBeta) Conference in San Jose, Calif., from May 6-9, 2024. Meeting attendees will be able to learn how to participate in the program throughout the conference in booth #312. View the press release.
Ansa Biotechnologies Appoints Jason T. Gammack as CEO
Gammack is joining the company as it completes its early access program and prepares for a full commercial launch of its rapid enzymatic synthesis for complex clonal genes and gene fragments. Founding CEO Dan Lin-Arlow, PhD, will remain with the company and transition to a new position as chief scientific officer. View the press release.
Advancing DNA Writing Technologies for Synthetic Genomes
Nature Biotechnology news feature on the promises and implications of new DNA synthesis technologies, featuring comments from Ansa Biotechnologies’ Dan Lin-Arlow.
Long DNA for Difficult Applications – Dan Lin-Arlow
Dan Lin-Arlow discusses Ansa’s groundbreaking de novo synthesis of the world’s longest oligo and their proprietary method in a podcast with Theral Timpson on the Mendelspod podcast. Explore the challenges of synthesizing long DNA, the impact of computation and AI in DNA synthesis, and more. Subscribe to Mendelspod to listen to the full podcast.
Ansa Pioneers Enzymatic DNA Synthesis for Synthetic Biology Innovation
Article in Forbes by John Cumbers, founder of SynBioBeta, tracing Ansa’s journey from concept to successful synthesis of the world’s longest oligonucleotide, showcasing their unique DNA synthesis technology and vision for the future of the industry.
Advancing Enzymatic DNA Synthesis for DNA-Intensive Applications
Microsoft and Ansa researchers describe a new approach toward ultra-high throughput enzymatic DNA synthesis on a chip in ACS Synthetic Biology. The method could be useful for DNA-based data storage and Synthetic Biology applications.